Of note, in a recent study [32] renal AT1 receptors were found to be required for the development of Ang II-dependent hypertension and cardiac hypertrophy suggesting that the major mechanism of action of RAS inhibitors in hypertension is attenuation of Ang II effects in the kidney. The gene discussed is AGTR1; the disease is hypertensive disorder.